Hostname: page-component-78c5997874-ndw9j Total loading time: 0 Render date: 2024-11-13T00:39:54.523Z Has data issue: false hasContentIssue false
  • English
  • Français

Tauopathies: One Disease or Many?

Published online by Cambridge University Press:  02 December 2014

Manon Bouchard  and
Oksana Suchowersky
Manon Bouchard*
Affiliation:
Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada
Oksana Suchowersky
Affiliation:
Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada Department of Medical Genetics, University of Calgary, Calgary, Alberta, Canada
*
3350 Hospital DR NW, Calgary, Alberta, T2N 4Z5, Canada
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Tauopathies are a group of disorders that have in common abnormal accumulation of tau protein in the brain. Although the different tauopathies have long been considered to be separate diseases, it is now clear that progressive supranuclear palsy, corticobasal degeneration and some forms of tau-positive frontotemporal lobar degeneration share clinical, pathological and genetic features. The important overlap between these disorders suggest they may represent different phenotypes of a single disease process, the clinical result depending on the topography of pathological lesions as well as other unknown factors.

Type
Review Article
Information
Canadian Journal of Neurological Sciences , Volume 38 , Issue 4 , July 2011 , pp. 547 - 556
Copyright
Copyright © The Canadian Journal of Neurological 2011

References

1.Williams, DR.Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau. Intern Med J. 2006;36(10):652–60.CrossRefGoogle ScholarPubMed
2.Gu, Y, Oyama, F, Ihara, Y.Tau is widely expressed in rat tissues. J Neurochem. 1996;67(3):1235–44.CrossRefGoogle ScholarPubMed
3.Müller, R, Heinrich, M, Heck, S, Blohm, D, Richter-Landsberg, C.Expression of microtubule-associated proteins MAP2 and tau in cultured rat brain oligodendrocytes. Cell Tissue Res. 1997;288 (2):239–49.Google ScholarPubMed
4.Couchie, D, Charrière-Bertrand, C, Nunez, J.Expression of the mRNA for tau proteins during brain development and in cultured neurons and astroglial cells. J Neurochem. 1988;50(6):1894–9.Google Scholar
5.Hirokawa, N.Microtubule organization and dynamics dependent on microtubule-associated proteins. Curr Opin Cell Biol. 1994;6(1): 74–81.CrossRefGoogle ScholarPubMed
6.van Herpen, E, Rosso, SM, Serverijnen, L, et al.Variable phenotypic expression and extensive tau pathology in two families with the novel tau mutation L315R. Ann Neurol. 2003;54(5):573–81.CrossRefGoogle ScholarPubMed
7.Josephs, K.Frontotemporal dementia and related disorders: deciphering the enigma. Ann Neurol. 2008;64(1):4–14.CrossRefGoogle ScholarPubMed
8.Schrag, A, Ben-Shlomo, Y, Quinn, NP.Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet. 1999;354(9192):1771–5.Google Scholar
9.Steele, JC, Richardson, JC, Olszewski, J.Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol. 1964;10:333–59.CrossRefGoogle ScholarPubMed
10.Williams, DR, Lees, AJ.Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol. 2009;8(3):270–9.CrossRefGoogle ScholarPubMed
11.Litvan, I, Agid, Y, Calne, D, et al.Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996;47(1):1–9.CrossRefGoogle ScholarPubMed
12.Rivaud-Péchoux, S, Vidailhet, M, Gallouedec, G, et al.Longitudinal ocular motor study in corticobasal degeneration and progressive supranuclear palsy. Neurology. 2000;54(5):1029–32.Google Scholar
13.Vidailhet, M, Rivaud, S, Gouider-Khouja, N, et al.Eye movements in parkinsonian syndromes. Ann Neurol. 1994;35(4):420–6.Google Scholar
14.Litvan, I, Grimes, DA, Lang, AE, et al.Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration. Neurology. 1999;246 Suppl II:1–5.Google Scholar
15.Scaravilli, T, Tolosa, E, Ferrer, I.Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting. Mov. Disord. 2005;20 Suppl 1:S21–8.CrossRefGoogle ScholarPubMed
16.Josephs, KA, Duffy, JR.Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy. Curr Opin Neurol. 2008;21(6): 688–92.Google Scholar
17.Kaat, LD, Boon, AJ, Kamphorst, W, et al.Frontal presentation in progressive supranuclear palsy. Neurology. 2007;69(8):723–9.Google Scholar
18.Maher, E, Smith, E, Lees, A.Cognitive deficits in the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). J Neurol Neurosurg Psychiatry. 1985: Dec;48(12):1234–9.CrossRefGoogle ScholarPubMed
19.Grafman, J, Litvan, I, Gomez, C, Chase, TN.Frontal lobe function in progressive supranuclear palsy. Arch Neurol. 1990;47(5):553–8.Google Scholar
20.Kertesz, A, McMonagle, P.Behavior and cognition in corticobasal degeneration and progressive supranuclear palsy. J Neurol Sci. 2010;289(1-2):138–43.Google Scholar
21.Birdi, S, Rajput, A, Fenton, M, et al.Progressive supranuclear palsy diagnosis and confounding features: report on 16 autopsied cases. Mov Disord. 2002 Nov;17(6):1255–64.Google Scholar
22.Dubas, F, Gray, F, Escourolle, R.Steele-Richardson-Olszewski disease without ophthalmoplegia. 6 clinico-anatomic cases. Rev Neurol (Paris). 1983;139(6-7):407–16.Google ScholarPubMed
23.Davis, P, Bergeron, C, McLachlan, D.Atypical presentation of progressive supranuclear palsy. Ann Neurol. 1985 Apr;17(4): 337–43.Google Scholar
24.Daniel, SE, de Bruin, VM, Lees, AJ.The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal. Brain. 1995;118 (Pt 3:759–70.Google Scholar
25.Williams, DR, de Silva, R, Paviour, DC, et al.Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson’s syndrome and PSP-parkinsonism. Brain. 2005;128(Pt 6):1247–58.CrossRefGoogle ScholarPubMed
26.Barclay, CL, Bergeron, C, Lang, AE.Arm levitation in progressive supranuclear palsy. Neurology. 1999;52(4):879–82.CrossRefGoogle ScholarPubMed
27.Oide, T, Ohara, S, Yazawa, M, et al.Progressive supranuclear palsy with asymmetric tau pathology presenting with unilateral limb dystonia. Acta Neuropathol. 2002 Aug;104(2):209–14. Epub 2002 Jun 5.Google Scholar
28.Motoi, Y, Takanashi, M, Itaya, M, et al.Glial localization of four-repeat tau in atypical progressive supranuclear palsy. Neuropathology. 2004;24(1):60–5.Google Scholar
29.Mizuno, T, Shiga, K, Nakata, Y, et al.Discrepancy between clinical and pathological diagnoses of CBD and PSP. J Neurol. 2005;252 (6):687–97.Google Scholar
30.Barclay, CL, Lang, AE.Dystonia in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry. 1997;62(4):352–6.Google Scholar
31.Boeve, BF, Maraganore, DM, Parisi, JE, et al.Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology. 1999;53(4):795–800.Google Scholar
32.Nath, U, Ben-Shlomo, Y, Thomson, RG, Lees, AJ, Burn, DJ.Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study. Neurology. 2003;60(6):910–6.Google Scholar
33.Masliah, E, Hansen, L, Quijada, S, et al.Late onset dementia with argyrophilic grains and subcortical tangles or atypical progressive supranuclear palsy? Ann Neurol. 1991 Apr;29(4): 389–96.Google Scholar
34.Keith-Rokosh, J, Ang, LC.Progressive supranuclear palsy: a review of co-existing neurodegeneration. Can J Neurol Sci. 2008;35(5): 602–8.Google Scholar
35.Josephs, KA, Petersen, RC, Knopman, DS, et al.Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology. 2006;66(1):41–8.Google Scholar
36.Josephs, K, Boeve, BF, Duffy, JR, et al.Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia. Neurocase. 2005;11(4):283–96.Google Scholar
37.Kertesz, A, McMonagle, P, Blair, M, Davidson, W, Munoz, DG.The evolution and pathology of frontotemporal dementia. Brain. 2005;128(Pt 9):1996–2005.Google Scholar
38.Knibb, JA, Xuereb, JH, Patterson, K, Hodges, JR.Clinical and pathological characterization of progressive aphasia. Ann Neurol. 2006;59(1):156–65.Google Scholar
39.Mochizuki, A, Ueda, Y, Komatsuzaki, Y, et al.Progressive supranuclear palsy presenting with primary progressive aphasia—clinicopathological report of an autopsy case. Acta Neuropathol. 2003 Jun;105(6):610–4. Epub 2003 Apr 1.Google Scholar
40.Boeve, B, Dickson, D, Duffy, J, et al.Progressive nonfluent aphasia and subsequent aphasic dementia associated with atypical progressive supranuclear palsy pathology. Eur Neurol. 2003;49 (2):72–8.Google Scholar
41.Josephs, KA, Dickson, DW.Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy brain bank. Mov Disord. 2003;18(9):1018–26.Google Scholar
42.Osaki, Y, Ben-Shlomo, Y, Lees, AJ, et al.Accuracy of clinical diagnosis of progressive supranuclear palsy. Mov Disord. 2004; 19(2):181–9.Google Scholar
43.Gearing, M, Olson, D, Watts, R, Mirra, S.Progressive supranuclear palsy: neuropathologic and clinical heterogeneity. Neurology. 1994 Jun;44(6):1015–24.Google Scholar
44.Shiozawa, M, Fukutani, Y, Sasaki, K, et al.Corticobasal degeneration: an autopsy case clinically diagnosed as progressive supranuclear palsy. Clin Neuropathol. 2000 Jul-Aug;19(4):192–9.Google Scholar
45.Ludolph, AC, Kassubek, J, Landwehrmeyer, BG, et al.Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. Eur J Neurol. 2009; 16(3):297–309.CrossRefGoogle ScholarPubMed
46.Hauw, J, Daniel, S, Dickson, D, et al.Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology. 1994 Nov;44(11):2015–9.Google Scholar
47.Feany, M, Mattiace, L, Dickson, D.Neuropathologic overlap of progressive supranuclear palsy, Pick’s disease and corticobasal degeneration. J Neuropathol Exp Neurol. 1996 Jan;55(1):53–67.Google Scholar
48.Litvan, I, Hauw, JJ, Bartko, JJ, et al.Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol. 1996;55(1):97–105.Google Scholar
49.Wakabayashi, K, Takahashi, H.Pathological heterogeneity in progressive supranuclear palsy and corticobasal degeneration. Neuropathology. 2004 Mar;24(1):79–86.CrossRefGoogle ScholarPubMed
50.Cordato, N, Halliday, G, McCann, H, et al.Corticobasal syndrome with tau pathology. Mov Disord. 2001 Jul;16(4):656–67.Google Scholar
51.Bergeron, C, Pollanen, MS, Weyer, L, Lang, AE.Cortical degeneration in progressive supranuclear palsy. A comparison with cortical-basal ganglionic degeneration. J Neuropathol Exp Neurol. 1997;56(6):726–34.Google Scholar
52.Tsuboi, Y, Josephs, KA, Boeve, BF, et al.Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome. Mov Disord. 2005;20(8):982–8.Google Scholar
53.Ikebe, S, Mori, H, Sumino, S, et al.A 77-year-old man with gait and gaze disturbance. Nō to Shinkei. 2000;52(3):269–79.Google Scholar
54.Williams, DR, Holton, JL, Strand, C, et al.Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson’s syndrome. Brain. 2007;130(Pt 6):1566–76.CrossRefGoogle ScholarPubMed
55.Williams, DR, Holton, JL, Strand, K, Revesz, T, Lees, AJ.Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy. Mov Disord. 2007;22(15): 2235–41.Google Scholar
56.Jellinger, K.Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy. Neurodegener Dis. 2008;5(6):339–46. Epub 2008 Mar 18.Google Scholar
57.Rebeiz, JJ, Kolodny, EH, Richardson, EP.Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol. 1968;18 (1):20–33.Google Scholar
58.Gibb, WR, Luthert, PJ, Marsden, CD.Corticobasal degeneration. Brain. 1989;112 (Pt 5):1171–92.Google Scholar
59.Wenning, GK, Litvan, I, Jankovic, J, et al.Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J Neurol Neurosurg Psychiatry. 1998;64(2):184–9.Google Scholar
60.Wadia, P, Lang, A.The many faces of corticobasal degeneration. Parkinsonism Relat Disord. 2007;13 Suppl 3:S336–40.Google Scholar
61.Lang, A, Riley, D, Bergeron, C.Cortical-basal ganglionic degeneration. In: Clane, DB, editor. Neurodegenerative diseases. Philadelphia: WB Saunders; 1994:877–94.Google Scholar
62.Grimes, DA, Lang, AE, Bergeron, CB.Dementia as the most common presentation of cortical-basal ganglionic degeneration. Neurology. 1999;53(9):1969–74.Google Scholar
63.Kertesz, A, Martinez-Lage, P, Davidson, W, Munoz, DG.The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia. Neurology. 2000;55(9): 1368–75.Google Scholar
64.Pillon, B, Blin, J, Vidailhet, M, et al.The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer’s disease. Neurology. 1995 Aug;45(8):1477–83.Google Scholar
65.Dubois, B, Slachevsky, A, Litvan, I, Pillon, B.The FAB: a Frontal Assessment Battery at bedside. Neurology. 2000;55(11):1621–6.Google Scholar
66.Kertesz, A, Munoz, D.Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy. Dement Geriatr Cogn Disord. 2004;17(4):282–6.Google Scholar
67.Blake, M, Duffy, J, Boeve, B, Ahlskog, E, Maraganore, D.Speech and language disorders associated with corticobasal degeneration. J Med Speech Lang Pathol 2003;11:131–46.Google Scholar
68.McMonagle, P, Blair, M, Kertesz, A.Corticobasal degeneration and progressive aphasia. Neurology. 2006;67(8):1444–51.Google Scholar
69.Grimes, DA, Lang, AE, Bergeron, CB.Dementia as the most common presentation of cortical-basal ganglionic degeneration. Neurology. 1999;53(9):1969-.CrossRefGoogle ScholarPubMed
70.Hodges, JR, Davies, RR, Xuereb, JH, et al.Clinicopathological correlates in frontotemporal dementia. Ann Neurol. 2004;56(3): 399–406.Google Scholar
71.Renner, J, Burns, J, Hou, C, et al.Progressive posterior cortical dysfunction: a clinicopathologic series. Neurology. 2004 Oct 12; 63(7):1175–80.Google Scholar
72.Tang-Wai, D, Graff-Radford, N, Boeve, B, et al.Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy. Neurology. 2004 Oct 12;63(7):1168–74.Google Scholar
73.Ikeda, K, Akiyama, H, Iritani, S, et al.Corticobasal degeneration with primary progressive aphasia and accentuated cortical lesion in superior temporal gyrus: case report and review. Acta Neuropathol. 1996;92(5):534–9.Google Scholar
74.Sakurai, Y, Hashida, H, Uesugi, H, et al.A clinical profile of corticobasal degeneration presenting as primary progressive aphasia. Eur Neurol. 1996;36(3):134–7.Google Scholar
75.Bergeron, C, Pollanen, MS, Weyer, L, Black, SE, Lang, AE.Unusual clinical presentations of cortical-basal ganglionic degeneration. Ann Neurol. 1996;40(6):893–900.Google Scholar
76.Mimura, M, Oda, T, Tsuchiya, K, et al.Corticobasal degeneration presenting with nonfluent primary progressive aphasia: a clinicopathological study. J Neurol Sci. 2001 Jan 15;183(1): 19–26.Google Scholar
77.Mathuranath, PS, Xuereb, JH, Bak, T, Hodges, JR.Corticobasal ganglionic degeneration and/or frontotemporal dementia? A report of two overlap cases and review of literature. J Neurol Neurosurg Psychiatry. 2000;68(3):304–12.Google Scholar
78.Revesz, T, Holton, JL.Anatamopathological spectrum of tauopathies. Mov Disord. 2003;18 Suppl 6:S13–20.Google Scholar
79.Tsuchiya, K, Ikeda, K, Uchihara, T, Oda, T, Shimada, H.Distribution of cerebral cortical lesions in corticobasal degeneration: a clinicopathological study of five autopsy cases in Japan. Acta Neuropathol. 1997;94(5):416–24.Google Scholar
80.Ikeda, K.Basic pathology of corticobasal degeneration. Neuropathology 1997;17:127–33.Google Scholar
81.Wakabayashi, K, Oyanagi, K, Makifuchi, T, et al.Corticobasal degeneration: etiopathological significance of the cytoskeletal alterations. Acta Neuropathol. 1994;87(6):545–53.Google Scholar
82.Su, M, Yoshida, Y, Hirata, Y, Satoh, Y.An autopsy case of corticobasal degeneration associated with atrophy of pons and cerebellum. Niigata Medical J. 1999;113:350–1.Google Scholar
83.Ohara, S, Tsuyuzaki, J, Oide, T, et al.A clinical and neuropathological study of an unusual case of sporadic tauopathy. A variant of corticobasal degeneration? Neurosci Lett. 2002;330(1):84–8.Google Scholar
84.Hattori, M, Yoshida, M, Ojika, K, et al.An autopsy case of corticobasal degeneration without prominent cortical pathology-an imitator of progressive supranuclear palsy. Rinshō Shinkeigaku. 2000;40(4):372–7.Google Scholar
85.Neary, D, Snowden, JS, Gustafson, L, et al.Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51(6):1546–54.Google Scholar
86.Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry. 1994;57(4):416–8.Google Scholar
87.Schneider, J, Watts, R, Gearing, M, Brewer, R, Mirra, S.Corticobasal degeneration: neuropathologic and clinical heterogeneity. Neurology. 1997 Apr;48(4):959–69.Google Scholar
88.Rinne, JO, Lee, MS, Thompson, PD, Marsden, CD.Corticobasal degeneration. Aclinical study of 36 cases. Brain. 1994;117 (Pt 5: 1183–96.Google Scholar
89.McKhann, GM, Albert, MS, Grossman, M, et al.Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick’s Disease. Arch Neurol. 2001;58(11):1803–9.Google Scholar
90.Forman, MS, Farmer, J, Johnson, JK, et al.Frontotemporal dementia: clinicopathological correlations. Ann Neurol. 2006;59(6): 952–62.Google Scholar
91.Josephs, K, Duffy, J, Strand, E, et al.Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain. 2006 Jun;129(Pt 6):1385–98.Google Scholar
92.Kertesz, A, Davidson, W, Munoz, DG.Clinical and pathological overlap between frontotemporal dementia, primary progressive aphasia and corticobasal degeneration: the Pick complex. Dement Geriatr Cogn Disord. 1999;10 Suppl 1:46–9.CrossRefGoogle ScholarPubMed
93.Dumanchin, C, Camuzat, A, Campion, D, et al.Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism. Hum Mol Genet. 1998;7(11):1825–9.Google Scholar
94.Hutton, M, Lendon, CL, Rizzu, P, et al.Association of missense and 5’-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 1998;393(6686):702–5.Google Scholar
95.Bugiani, O, Murrell, JR, Giaccone, G, et al.Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau. J Neuropathol Exp Neurol. 1999;58(6):667–77.Google Scholar
96.Soliveri, P, Rossi, G, Monza, D, et al.A case of dementia parkinsonism resembling progressive supranuclear palsy due to mutation in the tau protein gene. Arch Neurol. 2003;60(10): 1454–6.Google Scholar
97.Rademakers, R, Cruts, M, van Broeckhoven, C.The role of tau (MAPT) in frontotemporal dementia and related tauopathies. Human Mutation. 2004;24(4):277–95.Google Scholar
98.Ferrer, I, Pastor, P, Rey, MJ, et al.Tau phosphorylation and kinase activation in familial tauopathy linked to deln296 mutation. Neuropathol Appl Neurobiol. 2003;29(1):23–34.Google Scholar
99.Pastor, P, Pastor, E, Carnero, C, et al.Familial atypical progressive supranuclear palsy associated with homozigosity for the delN296 mutation in the tau gene. Ann Neurol. 2001;49(2): 263–7.Google Scholar
100.Rossi, G, Marelli, C, Farina, L, et al.The G389R mutation in the MAPT gene presenting as sporadic corticobasal syndrome. Mov Disord. 2008 Apr 30;23(6):892–5.Google Scholar
101.Stanford, P, Halliday, G, Brooks, W, et al.Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: expansion of the disease phenotype caused by tau gene mutations. Brain. 2000 May;123 (Pt 5):880–93.Google Scholar
102.Bird, TD, Nochlin, D, Poorkaj, P, et al.A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L). Brain. 1999;122 (Pt 4:741–56.Google Scholar
103.Ksiezak-Reding, H, Morgan, K, Mattiace, LA, et al.Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration. Am J Pathol. 1994;145(6):1496–508.Google Scholar
104.Buée Scherrer, V, Hof, PR, Buée, L, et al.Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick’s disease. Acta Neuropathol. 1996;91(4):351–9.Google Scholar
105.Buée, L, Delacourte, A.Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick’s disease. Brain Pathol. 1999;9(4):681–93.Google Scholar
106.Tellez-Nagel, I, Wiśniewski, H.Ultrastructure of neurofibrillary tangles in Steele-Richardson-Olszewski syndrome. Arch Neurol. 1973 Nov;29(5):324–7.Google Scholar
107.Arai, T, Ikeda, K, Akiyama, H, et al.Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer’s disease, Pick’s disease, progressive supranuclear palsy and corticobasal degeneration. Acta Neuropathol. 2003;105(5):489–98.Google Scholar
108.Berry, RW, Sweet, AP, Clark, FA, et al.Tau epitope display in progressive supranuclear palsy and corticobasal degeneration. J Neurocytol. 2004;33(3):287–95.Google Scholar
109.Arai, T, Ikeda, K, Akiyama, H, et al.Intracellular processing of aggregated tau differs between corticobasal degeneration and progressive supranuclear palsy. Neuroreport. 2001;12(5):935–8.Google Scholar
110.Arai, T, Ikeda, K, Akiyama, H, et al.Identification of amino-terminally cleaved tau fragments that distinguish progressive supranuclear palsy from corticobasal degeneration. Ann Neurol. 2004;55(1):72–9.Google Scholar
111.Tuite, PJ, Clark, HB, Bergeron, C, et al.Clinical and pathologic evidence of corticobasal degeneration and progressive supranuclear palsy in familial tauopathy. Arch Neurol. 2005;62 (9):1453–7.Google Scholar
112.Li, F, Iseki, E, Kosaka, K, et al.Progressive supranuclear palsy with fronto-temporal atrophy and various tau-positive abnormal structures. Clin Neuropathol. 1996 Nov-Dec;15(6):319–23.Google Scholar
113.Katsuse, O, Iseki, E, Arai, T, et al.4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol. 2003;106(3):251–60.CrossRefGoogle ScholarPubMed
114.Tan, C, Piao, Y, Kakita, A, et al.Frontotemporal dementia with co-occurrence of astrocytic plaques and tufted astrocytes, and severe degeneration of the cerebral white matter: a variant of corticobasal degeneration? Acta Neuropathol. 2005;109(3): 329–38.Google Scholar
115.Di Maria, E, Tabaton, M, Vigo, T, et al.Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy. Ann Neurol. 2000 Mar;47(3):374–7.Google Scholar
116.Houlden, H, Baker, M, Morris, HR, et al.Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology. 2001;56(12):1702–6.Google Scholar
117.Baker, M, Litvan, I, Houlden, H, et al.Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet. 1999;8(4):711–5.Google Scholar
118.Conrad, C, Andreadis, A, Trojanowski, J, et al.Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol. 1997 Feb;41(2):277–81.Google Scholar
119.Morris, HR, Janssen, JC, Bandmann, O, et al.The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases. J Neurol Neurosurg Psychiatry. 1999;66(5):665–7.Google Scholar
120.Hughes, A, Mann, D, Pickering-Brown, S.Tau haplotype frequency in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Exp Neurol. 2003;181(1):12–6.Google Scholar
121.Panegyres, PK, Zafiris-Toufexis, K.Polymorphisms in the tau gene in sporadic frontotemporal dementia and other neuro-degenerative disorders. Eur J Neurol. 2002;9(5):485–9.Google Scholar
122.Gallo, M, Tomaino, C, Puccio, G, et al.Novel MAPT Val75Ala mutation and PSEN2 Arg62Hys in two siblings with frontotemporal dementia. Neurol Sci. 2010;31(1):65–70.Google Scholar
123.Seelaar, H, Rohrer, JD, Pijnenburg, YAL, Fox, NC, van Swieten, JC.Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review. J Neurol Neurosurg Psychiatry. 2011 May;82(5):476–86. Epub 2010 Oct 22.Google Scholar